Want to join the conversation?
$COF earned $1.99 per share on a continuing operations basis. Net income was up $251MM vs. 3Q14 driven by higher linked quarter pre-provision earnings and slightly lower provision expense. The company had $188MM of non-recurring OpEx in 2Q15. Excluding non-recurring expenses, OpEx were flat vs. the prior year.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.